HRV Analysis Could Unlock Precision Treatment for Insomnia-Sleep Apnea Overlap

Sleep disorders rarely occur in isolation, and the overlap between insomnia and obstructive sleep apnea — known as COMISA — represents one of the most clinically challenging combinations in sleep medicine. Patients with COMISA tend to have worse outcomes than those with either condition alone, and standard treatments like CPAP or cognitive behavioral therapy for insomnia often fall short when applied without accounting for the comorbid disorder.

This paper, published in Sleep, argues for the use of heart rate variability as a tool for autonomic phenotyping in COMISA. HRV reflects the balance between sympathetic and parasympathetic branches of the autonomic nervous system, and disruptions in this balance are well-documented in both insomnia and sleep apnea independently. Combining these disorders may produce distinct autonomic signatures that differ meaningfully between patient subgroups.

The authors propose that identifying these autonomic phenotypes could guide more targeted treatment selection. For example, patients with hyperarousal-driven insomnia overlapping with apnea may require different interventions than those whose insomnia is primarily apnea-fragmentation-driven. HRV offers a non-invasive, continuous, and increasingly accessible metric to distinguish these profiles.

The clinical implications are significant. As wearable devices capable of measuring HRV become mainstream, integrating autonomic data into sleep assessments could transform routine clinical practice. This framework could reduce trial-and-error in treatment and improve long-term adherence and outcomes for a population that has historically been underserved.

That said, this appears to be a commentary or editorial rather than an original research study, meaning the proposals are conceptual at this stage. Validation through large prospective trials will be essential before HRV-based autonomic phenotyping becomes a clinical standard.